Subacute toxicopathological studies of methotrexate in Wistar rats by N. N. Patel et al.
doi:
How to cite this article:
10.14202/vetworld.2014.
Patel NN, Ghodasara DJ, Pandey S, Ghodasara PD, Khorajiya JH, Joshi BP and Dave CJ (2014)
Subacute toxicopathological studies of methotrexate in Wistar rats, 7(7): 489-495. Veterinary World
489-495
Introduction
Materials and Methods
Methotrexate (MTX), a folic acid antagonist,
currently used as a disease modifying anti-rheumatic
drug (DMARD) along with non-steroidal anti-infla-
mmatory drugs (NSAIDs) to provide the best possible
relief to rheumatoid arthritis patients in low doses (2.5
mg–15mg/week)[1]. Rheumatoidarthritisisachronic,
systemic, autoimmune, inflammatory disorder of
humans and animals like dog and horse which
primarily affects joints resulting in non-suppurative
proliferative synovitis [2]. Methotrexate is also used
aloneorincombinationwithotheranticanceragentsin
the treatment of breast cancer, epidermoid cancers of
theheadandneckandlungcancer[3].
With the widespread use of methotrexate, a well-
definedtoxicityprofilehasemerged[4].Methotrexate
exerts its primary toxic effects against the rapidly
replicating cells of the bone marrow and gastrointes-
tinal epithelium producing leucopoenia and thrombo-
cytopenia. Long term administration of the same causes
anaemia. Methotrexate also causes kidney damage,
which is a frequent complication of high-dose therapy.
Bothlowandhigh-dosetherapycancausehepatotoxicity.
High-dose therapy results in elevated liver enzymes
and low dose therapy produces a different type of
hepatotoxicity which includes cirrhosis. Methotrexate
atverylowdosageaffectstheliverandcauseschanges
inhistologyofliverinrat[5].Otherfrequentlyreported
adverse toxic effects are malaise, nausea, vomition,
diarrhoea,headache,mildalopeciaandfever[6].
Toxic side effects of methotrexate have been
demonstrated in various animals including rat, mice,
rabbit and dog. Methotrexate seems to be hepatotoxic,
nephrotoxic and toxic to respiratory and reproductive
system at very low doses for continuous therapy. The
present study was conducted to examine the subacute
toxicopathologicaleffectsofmethotrexateinWistarrats.
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A toxico-pathological study was undertaken to assess the effects of Methotrexate administration in Wistar rats by
performingthehematology,serumbiochemicalanalysisandassociatedhistopathologicalchangesinvisceralorgans.
Rats in 4 treatment groups with 6 male and 6 female rats each were administered methotrexate
(Group II to IV) at the dose rate of 0.062, 0.125 and 0.250 mg/kg body weight respectively and distilled water (Group I) as
vehiclecontrolfor28days.Hematologicalparametersviz.,totalerythrocytecount,haemoglobin,packedcellvolume,MCV,
MCH and MCHC, total leukocyte count and differential leukocyte count and serum biochemical parameters viz., aspartate
aminotransferase, alanine aminotransferase, alkaline phosphatase, serum creatinine, blood urea nitrogen, total protein,
albumin, globulin (Calculated) were estimated after 28 days. Necropsy examination was performed in all sacrificed animals
and gross lesions were recorded. Tissue samples (lung, liver, kidney, intestine, testes and heart) were collected in 10%
formalinsolutionforhisto-pathologicalexamination.
The dose dependent reduction in body weight, feed consumption, RBCs count, packed cell volume, haemoglobin,
total leucocyte count, neutrophil count, total protein and albumin was observed in animals of group II, III and IV along with
significant increase in lymphocyte count,AST,ALT,AKP, creatinine and BUN in animals of methotrexate treated group IV
followed by group III. No significant change in monocyte, eosinophil and basophil counts were observed in any treatment
groups. All the rats exposed to methotrexate at three different dose levels revealed dose dependent pathological changes
characterizedbydegeneration,necrosis,congestion,haemorrhageandvascularchanges.Themaintargetorgansaffectedwere
liver,kidney,lungsandtestes.
Itcanbeconcludedfromthisstudythatsub-acuteexposuretomethotrexateproducednoappreciablechangesat
recommended 0.062 mg/kg body weight dose level. The findings observed at 0.250 mg/kg body weight methotrexate dose
levelareofpublichealthsignificanceandregulatoryimportanceduetoitshepatotoxicandnephrotoxiccharacter.
biochemicalparameters,histopathology,methotrexate,Wistarrats.
RESEARCH ARTICLE
Open Access
Veterinary World, EISSN: 2231-0916 489
Copyright: The authors. This article is an open access article licensed
under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0) which permits
unrestricted use, distribution and reproduction in any medium,
provided the work is properly cited.Available at www.veterinaryworld.org/Vol.7/July-2014/9.pdf
Veterinary World, EISSN: 2231-0916 490
ofVeterinaryCollege,AnandAgricultureUniversityhas
accordedpermissionforconductingthisbiologicaltrial.
Study was conducted on colony-bred 7-8
weeks old, adult male and female albino wistar rats,
procuredfromDivisionofPharmacologyandToxicology,
Cadila Pharmaceuticals Limited, Dholaka, Gujarat,
India.Theratswerehousedinlaboratoryanimalhouse
inpolypropylenecagesandweighedweeklyduringthe
study.Feedanddistilledwaterwereprovided
All the 48 rats were randomly divided into 4 different
groups. Each group consisted of 6 male and 6 female
rats. The groups were numbered as group I to IV. The
group I served as control and received only vehicle
(Distilled water), while group II, III and IV received
methotrexateatdosesof0.062mg/kg(lowdose),0.125
mg/kg(middose)and0.250mg/kg(highdose)respec-
tively by oral gavage for 28 days of dosing period. At
theendof28days .terminationofexperiment,allthe
ratsweresubjectedtoterminalsacrificebyhighdoseof
anesthesia with Di-ethyl ether, after blood collection
fromretro-orbitalplexuswiththehelpofcapillarytube
asdescribedbySorgandBuckner[7].
Hematological parameters were
analyzedbyautomaticwholebloodanalyzerlikeTLC,
DLC,TEC,Hb,PCV,MCV,MCHandMCHC.
Biochemical estimations
were carried out by using diagnostic kits (Merck
Limited, India Ecoline Range) regarding AST, ALT,
AKP, Serum creatinine, BUN,Total protein,Albumin
andGlobulin(Calculated).
Tissue samples from liver, kidney,
lung, spleen, heart, intestine and testes were collected
and preserved in 10% neutral buffer formalin for
furtherhistopathologicalexamination.
Male and female animals of group I (control) and
II did not reveal any symptoms attributable to the 28
days administration of methotrexate. Two male and
one female were found to be diarrhoeic in last week of
experimental period in group III animals. Signs like
dullness and lethargy were noticed in seven rats (four
male and three female) of group IV animals. Two
animalsrevealeddiarrhoeainthirdweekofexperiment
in high dose group whereas all other animals were
found to be diarrhoeic in last week of experimental
periodingroupIVanimals.
Increaseinlivebodyweightwasfoundinthemale
andfemaleratsofgroupI(control)from0to28 dayof
exposure. While methotrexate treated rats of group III
and IV showed weight loss on seventh day onward,
there was no significant (p <0.05) change observed in
body weight of male and female rats belonging to
group II as compared to the respective control group I
rats. The most significant (p < 0.01) dose dependent
reduction in body weight in male rats at 28 day of
experiment was observed in group IV (255.05 g)
followed by significant reduction in group III (335.33
g) as compared with control group I (368.53 g) rats. In
the treatment groups of female rats also, the dose
dependentreductioninbodyweightgainwasobserved
in last week of experiment as compared to the control
groupexceptgroupII.
Dose dependent highly significant (p < 0.01)
reduction in mean values of feed consumption was
observedthroughouttheexperimentingroupIIIandIV
ascomparedtocontrolgrouprats.
Hematological study revealed that there was a
highly significant reduction (p< 0.01) in RBC, Hb,
PCV,WBC, neutrophil, lymphocytes of group IVmales
and in RBC and WBC of group IV females.Asignifi-
cant increase (p< 0.05) was also observed in MCV,
MCH of group IV males, WBC and neutrophils of
group III males, Hb, PCV, MCV, MCH, neutrophils,
lymphocytes of group IV females and WBC of group
IIIfemales.TherestoftheratsfromgroupIIandIIIdid
notrevealanysignificantchangeintheabovementioned
parameters as compared to control rats. No rat was
observed with any significant change in MCHC,
monocytes, basophils and eosinophils as compared to
controlrats(Table-1a,1b).
There is a highly
significant increase (p< 0.01) observed in AST, ALT,
AKP, Creatinine, BUN, total protein and albumin of
group IV male and female rats and significant change
(p<0.05)observedinmaleandfemaleratsofgroupIII
(Table-2a and 2b). There was no significant change
observedinglobulinvalueinanyofthegroups.
Grossly, no appreciable changes were observed
in group I (control) and group II rats while liver was
larger,paleandfattyintreatmentgroupIIIandIVwith
mildtomoderatecongestiononitssurface.
Histopathological changes in liver of rats treated
Medication:
Hematology:
Serum-biochemical analysis:
Histopathology:
Serum biochemical parameters:
Histopathology
Liver:
adlibitum.
i.e
Results
th
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Table-1a: Mean hematological values in different experimental groups.
Group Dose (mg/kg) Sex RBC (X10 /µL) WBCs(X10 /µL) Differential WBCs
N (%) L (%) M (%) E (%) B(%)
Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE
63
I Control(0 mg/kg) M 7.20 0.04 9.37 0.65 21.50 0.64 73.10 0.58 3.20 0.19 1.70 0.11 0.50 0.05
II 0.062 mg/kg M 7.48 0.14 8.28 0.13 21.40 0.12 72.90 0.26 3.60 0.13 1.50 0.17 0.60 0.04
III 0.125 mg/kg M 7.35 0.18 7.21* 0.25 19.33* 0.32 74.44 0.31 3.66 0.29 2.08 0.22 0.48 0.05
IV 0.250 mg/kg M 6.40** 0.14 3.30** 0.08 16.29** 0.58 77.07** 0.49 3.77 0.20 2.20 0.27 0.67 0.07
I Control (0 mg/kg) F 7.12 0.06 7.48 1.05 21.63 1.71 72.72 0.16 3.55 0.16 1.60 0.15 0.50 0.04
Mean SE
N: Neutrophil, L: Lymphocyte, M: Monocyte, E: Eosinophil, B: Basophil, *: Significant (p < 0.05); **: Highly significant (p < 0.01)Available at www.veterinaryworld.org/Vol.7/July-2014/9.pdf
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with different dose levels revealed dose dependent
variation in degeneration as well as vascular changes.
Mild to moderate granularity of hepatocytes and fatty
changes were observed in the animals of group III.
Animals of group IV showed vacuolar degeneration
andthecentralveinwasdilatedandcongested.Atsome
places, sinusoids were found dilated and pronounced
scattered hemorrhages with distortion of hepatic cords
(Figure-1)ingroupIVrats.
Sections from most of the animals in group III
showed severe congestion and vacuolar degeneration
of tubular epithelium (Figure-2). Sections from all the
animals of group IV showed mild to moderate tubular
necrosis (Figure-3) with vacuolar degeneration in the
cytoplasm of tubular cells. Lesions in group III and IV
ratswerenotonlyrestrictedtotubulesbutwerealsoobserved
Kidney:
Table-1b: Mean hematological values in different experimental groups.
Group Dose Sex Hb (g/dL) PCV (%) MCV (fL) MCH (pg)                MCHC (g/dL)
Mean SE Mean SE Mean SE Mean SE Mean SE
I Control(0 mg/kg) M 14.30 0.03 42.90 0.23 59.58 0.70 19.86 0.36 33.34 0.18
II 0.062 mg/kg M 14.56 0.23 43.68 0.69 58.42 0.23 19.48 0.08 33.33 0.01
III 0.125 mg/kg M 14.45 0.19 43.35 0.56 59.06 0.65 19.60 0.23 33.32 0.01
IV 0.250 mg/kg M 13.35** 0.16 40.02** 0.48 62.57* 0.67 20.86* 0.22 33.34 0.01
I Control (0 mg/kg) F 14.25 0.24 42.74 0.72 59.95 0.57 19.98 0.21 33.34 0.01
II 0.062 mg/kg F 14.37 0.23 43.11 0.70 59.45 0.44 19.83 0.15 33.33 0.01
III 0.125 mg/kg F 14.12 0.17 42.34 0.52 59.64 0.18 19.88 0.06 33.34 0.01
IV 0.250 mg/kg F 13.48* 0.12 40.45* 0.37 62.23* 0.44 20.74* 0.15 33.33 0.01
Table-2a: Mean values of serum biochemical parameters in males of different experimental groups
Biochemical parameter Group I Control (0 mg/kg) Group II (0.062 mg/kg) Group III (0.125 mg/kg) Group IV (0.250 mg/kg)
Mean SE Mean SE Mean SE Mean SE
AST (IU/L) 141.20 0.81 142.50 1.46 150.90* 2.63 161.60** 1.24
ALT (IU/L) 45.20 0.43 47.30 1.73 48.00* 0.87 58.30** 0.92
AKP (IU/L) 162.20 1.22 160.20 1.19 167.50* 1.63 198.00** 1.07
Creatinine (mg/dL) 0.48 0.04 0.56 0.02 0.61* 0.02 0.84** 0.01
BUN (mg/dL) 14.20 0.88 15.40 0.33 17.00* 0.23 19.90** 0.34
Total protein (g/dL) 7.12 0.10 6.90 0.11 6.48* 0.20 5.98** 0.07
Albumin (g/dL) 4.15 0.05 4.04 0.04 3.83* 0.09 3.22** 0.05
Globulin (g/dL) 2.97 0.13 2.85 0.10 2.64 0.16 2.76 0.09
Table-2b: Mean values of serum biochemical parameters in males of different experimental groups
Biochemical parameter Group I Control (0 mg/kg) Group II (0.062 mg/kg) Group III (0.125 mg/kg) Group IV (0.250 mg/kg)
Mean SE Mean SE Mean SE Mean SE
AST (IU/L) 142.30 1.41 143.80 1.19 150.90* 2.53 160.40** 0.69
ALT (IU/L) 42.10 0.40 43.20 0.57 44.50* 0.69 57.70** 0.86
AKP (IU/L) 156.20 1.58 155.10 1.15 162.80* 1.92 195.10** 2.33
Creatinine (mg/dL) 0.49 0.04 0.58 0.02 0.64* 0.02 0.82** 0.01
BUN (mg/dL) 14.50 0.84 15.80 0.19 16.90* 0.21 19.90** 0.24
Total protein (g/dL) 7.22 0.09 6.98 0.07 6.56* 0.19 6.14** 0.10
Albumin (g/dL) 4.18 0.07 4.00 0.04 3.83* 0.12 3.32** 0.05
Globulin (g/dL) 3.04 0.12 2.97 0.04 2.73 0.20 2.82 0.14
*: Significant (p < 0.05); **: Highly significant (p < 0.01)
*: Significant (p < 0.05); **: Highly significant (p < 0.01)
*: Significant (p < 0.05); **: Highly significant (p < 0.01)
Figure-1: Section of liver from group IV showing sinusoidal
haemorrhages with distortion of hepatic cords. H&E, X300.
Figure-2: Section of Kidney from group III showing
congestion and vacuolar degeneration of tubular epithelium.
H & E, X300.Available at www.veterinaryworld.org/Vol.7/July-2014/9.pdf
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in glomeruli, there was increased space between the
parietal and visceral layers of Bowman's capsule and
focalinfiltrationofmononuclearcells.IngroupIIIand
group IV rats, in addition to degenerative changes,
moderate to severe vascular changes characterized by
hemorrhagesinbetweenthetubuleswereobserved.
Grossly, testes of group IV rats were swollen
and showed bulging at cut surface, unlike in group I, II
and III. The testes of rats of group IV showed mild
atrophy of seminiferous tubules and mild to moderate
sloughing of germ cells (Figure-4). No histopatholo-
gical lesions were observed in testes of rats of group I,
IIandIII.
No histopathological lesions were
observedinepididymisofratsofcontrolgroupI,IIand
III. The histopathological lesions observed in
epididymis of rats of group IV showed reduced sperm
concentrationinepididymaltubules(Figure-5).
Gross lesions in lung were mainly characterized
bymildtomoderatecongestionandemphysemainrats
belonging to group III and IV as compared to group II
and control. Microscopic changes in lungs of group III
animals revealed congestion and hemorrhages in the
alveoli. Besides these, pulmonary emphysema charac-
terized by distension and dilatation of alveoli was also
evident at some places. Microscopically emphysema,
thickening and mononuclear cell infiltration in
interstitial space (Figure-6) and focal haemorrhages
werenoticedintheanimalsofgroupIV.
Nogrosspathologicallesionswereobservedin
any of the treatment group except mild congestion and
enlargementofspleenwithvaryingdegreeofdeposition
ofhaemosiderinpigments(Figure-7)infewanimalsof
groupIVascomparedtothecontrol.
No gross lesions were seen in group I
(control) and group II animals unlike group IV which
showed mild congestion in mucosa. The microscopic
lesionswerecharacterizedbydesquamationanddenu-
dation of surface epithelium of the villi leading to
erosions and necrosis. The necrotic area on the villi
showedneutrophilicinfiltration(Figure-8)ingroupIV
rats. Section of intestine from group I (control), II and
IIIanimalsdidnotrevealanyhistopathologicalchanges.
It was found in present study that high dose of
methotrexate causes gastrointestinal toxicity in rats
whichresultedindiarrhoeaandnasalbleeding.Similar
results were also reported by Ermens . [8] and
Boukhettala [9]. In the present study, clinical
Testes:
Epididymis:
Lung:
Spleen:
Intestine:
Discussion
et al
et al.
Figure-3: Section of kidney from group IV showing mild
tubular necrosis. H&E, X300.
Figure-4: Section of Testis from group IV showing
sloughing of germ cells. H&E, X150
Figure-5: Section of epididymis from group IV showing
reduced sperm concentration (arrow). H&E, X150.
Figure-6: Section of lung from group IV showing thickening
and infiltration of mononuclear cells in the interstitial space.
H&E, X150.Available at www.veterinaryworld.org/Vol.7/July-2014/9.pdf
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signslikedullnessandlethargydevelopedastherewas
decrease in feed consumption and body weight due to
methotrexate toxicity. Group III and IV animals
showed diarrhoea, the possible reason for these could
be corrosive and irritating effects of methotrexate on
gastrointestinal mucosa. No mortality was found in
anydosegroups.Weightlossinmethotrexatetreatedrats
might be a reflection of direct toxicity, reduced feed
andwaterintakeandstressogenicactivity,whicharein
agreement with earlier studies carried out by Periana-
yagasamy [10] and Karri andVanithakumari[11]
intheirstudies.
Significant decrease in RBCs counts were
observedinthetreatmentgroupIVandWBCcountsin
group III and IV. The change in RBCs count can be
attributed to ulcers in the digestive tract resulting in
gradual blood loss which supports the findings of the
Ohbayashi [12]. Decrease in PCV values in
treatmentgroupIVratscouldbeduetocytotoxiceffect
of methotrexate on haemopoietic system as evident
from state of anemia. Similar observations of decrease
inWBC counts were also made by Rofe . [13] and
Bussanich . [14]. Decreased feed consumption
leading to hypoproteinemia could be another possible
cause for lower haemoglobin seen in the present study.
Thefindingsofthecurrentstudyareinaccordancewith
Ohbayashi . [12] who treated mice with metho-
trexateatthedoseof3,10and15mg/kgfor28consecutive
days and observed decreased level of Hb and PCV in
dose dependent manner. Rofe . [13] reported the
hematological changes in female dark agouti rats
treated with methotrexate at the dose rate of 0.5 mg/kg
twointramuscularinjections,24hoursapartandobserved
the slight increase (but not significant) in levels of Hb
andPCV.
In present study, decrease in the neutrophil count
was observed with increase in lymphocyte count in
high dose group. Similarly, Robert . [15] reported
the systemic effect of methotrexate at the dose rate of
1.7 mg or 5 mg intraperitoneally every 48 hours in
guineapigsandobservedthatthedifferentialleucocyte
counts changed from 66% lymphocytes before drug
administration to 90% after 2 weeks and polymorpho-
nuclearcountsdroppedfrom34to10%duringthisperiod.
In the present study, group III and IV had
significant increase in the value of AST which are in
accordance with the findings of Vaghasiya . [16]
who evaluated the effect of polyherbal formulation on
methotrexate induced hepatotoxicity in rats at the dose
rate of 1 mg/kg/p.o./week for 3 weeks and exhibited
significantincreaseinlevelsofAST.Increasedlevelof
AST indicated damage caused by methotrexate
toxicitytothevisceralorgans.
Significant increase in the value ofALT in group
III and IV are in accordance with Uraz . [17] who
reported increased levels of ALT by single dose of
methotrexate. Vaghasiya . [16] also reported
increase in level ofALT in their study.ALT enzyme is
liverspecificandpresentinhepatocytecytoplasm[18].
Increased ALT level in present study indicates liver
damage in the rats exposed to 0.125 mg/kg b. wt/day
and0.250mg/kgb.wt/dayadministrationofmethotrexate.
Perianayagasamy . [10] evaluated the
therapeuticaleffectofmelatoninandglutamineagainst
rats bone marrow toxicity induced by methotrexate in
rat.Methotrexatewasgiveninratatthedoserateof400
µg/150gofbodyweightfor7daysandshowedincrease
in alkaline phosphatase level. Similar observations were
alsomadebyVaghasiya .[16]andUraz .[17].
Increase in the level ofAKPin group III and group IV
indicated significant damage to the body tissues by
methotrexateresultinginliberationofAKPinserum.
In present study, there was highly significant
increase in the levels of creatinine and BUN in metho-
trexate treated group IV, significant increase in group
III and a slight but not significant increase in group II.
These results indicate that the reduction in renal
filtrationratecanbeduetotoxiceffectofmethotrexate
on kidney. This is supported by histopathological
observation on kidney tissue revealing tubular dege-
nerationandnecrosisintreatmentgroups.
Similar findings of decrease in total protein and
et al.
et al.
et al
et al
et al
et al
et al
et al
et al
et al
et al
etal etal
Figure-7: Section of spleen of group IV showing deposition
of haemosiderin pigment. H&E, X300.
Figure-8: Section of intestine from group IV showing
necrosis at the tip of villi with neutrophilic infiltration. H&E,
X150.Available at www.veterinaryworld.org/Vol.7/July-2014/9.pdf
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albumin and no significant change in globulin were
alsoreportedbyVaghasiya .[16].Decreaseinlevel
of total protein is also in accordance with the findings
of Perianayagasamy . [10]. Reduction in serum
total protein and serum albumin induced by metho-
trexate treatment could be due to several factors like
damage to liver, increased intestinal protein loss,
protein-losing nephropathy and dietary protein
deficiencyastherewasdecreaseinfeedintake.
Al-motabagani [19] reported the histological and
histochemicalstudiesontheeffectsofmethotrexateon
theliverofadultmalealbinoratandshowedheavycell
infiltration around the portal tract and vacuolation of
the cytoplasm of hepatocyte.Vaghasiya . [16] also
showed vacuolation, degeneration of hepatocyte and
mild inflammation. Asci . [20] revealed similar
histopathological changes such as focal inflammatory
cellinfiltrations,vascularcongestion,sinusoidaldilatation
and granular degeneration of hepatocytes. The results
of present study indicated that the methotrexate has a
direct participation in liver structures alterations and
causesthecytotoxicityofhepatocyteswithvacuolation
of hepatic cytoplasm. These types of changes in the
tissues might be due to hypoxia as a result of anaemia
which causes mild and easily reversible changes in
parenchymatousorgans.
The kidney lesions in group III and IV were in
accordance with the findings of Chelab and Mazeed
[21] whostudiedhistopathologicalchangesinkidneys
due to prolonged treatment (6 months) with anticancer
chemotherapeutic agent namely methotrexate and
showedthedamageandseveretoxicityinrenalconvoluted
tubules and glomeruli in kidneys. Histopathological
findings in kidneys are in agreement with the bio-
chemical findings like increased levels of serum
creatinine, due to decrease in glomerular filtration rate
of methotrexate and its metabolites from kidneys,
which may lead to kidney lesions because of irritation
causedbydepositionofmethotrexatecrystalinnephrons
causingthenephrotoxicity[22].
Histopathological lesions of testes were in
accordancewithArash .[23]whostudiedtheeffect
ofgrowthhormoneonrecoveryfromtesticulardamage
induced by methotrexate in rats at the dose rate of 1
mg/kg/weekintraperitoneallyfor4weeksandconfirmed
the destructive effects of methotrexate on testicular
germinal cells with decrease in sperm count. Khulood
. [24] reported significant (p <0.05) decrease in
diametersofseminiferoustubules,primaryspermatocytes
and spermatids and increased interstitial spaces in
comparison to control while studying the effects of
aqueous extract of Salvia on some parameters of
spermsandhistopathologicalchangesintestesofmice
treated with methotrexate. Similar observations were
also made by Safavi . [25] by administration of
1mg/kg methotrexate intraperitonially for 28 conse-
cutivedaysinrats.
Histopathological lesions of lungs suggest that
methotrexate could induce alveolar epithelial cell
injury and resulted in the loss of integrity of the alveolar
capillarybarrierbasementmembranesfollowedbythe
recruitment and proliferation of myofibroblasts which
may cause the thickening of alveolar septa and mono-
nuclear cell infiltration in interstitial space. Similar
observations were also reported by Ohbayashi .
[12] in their study in which they treated mice with
methotrexateatadoseof3mg/kgonceadayfor21,28,
and 35 consecutive days.After 35 days, alveolar septa
were increased slightly along with hyperplasia of
interstitialtissueascomparedwithcontrolanimals.
Histopathologicalresultsofintestineweresimilar
to the findings of Boukhettala . [9] who reported
markeddecreaseofvillousheightatdayfour,inflamm-
ation and intestinal epithelial necrosis in the male
Sprague Dawley rats which received subcutaneous 2.5
mg/kgofmethotrexatefor3days.
Methotrexate administration at recommended
dosage (0.062 mg/kg/body weight) revealed no appre-
ciable changes while high dosage (0.250 mg/kg/body
weight) showed decrease in body weight and feed
consumption, Hb, PCV, TEC, TLC, neutrophil counts,
serum total protein and albumin values and significant
increase in MCV, MCH and lymphocyte count.
Significant increase in the AST, ALT, AKP, creatinine
and BUN were suggestive of histopathological lesions
observed in liver and kidney. Finally it can be
concluded from this study that sub-acute exposure to
methotrexate produced no appreciable changes at
recommended 0.062 mg/kg body weight dose level.
The findings observed at 0.125 and 0.250 mg/kg body
weight methotrexate dose level are of public health
significanceandregulatoryimportance.
Thisstudyisthemajorcomponentoftheworktowards
the M.V.Sc thesis of NNP, under the guidance of the
second author DJG. NNP conducted the experimental
trialsandorganizedthemanuscriptandDJGthoroughly
revised the same. BPJ and CJD were the members of
theadvisorycommitteefortheresearchwork.SP,PDG
and JHK were responsible for the housing and mana-
gementofratsandhelpedinpostmortemexamination,
blood collection, serum biochemical investigation,
data analysis and interpretation. All authors read and
approvedthefinalmanuscript.
The authors express profound gratitude toAnand
Agricultural University (AAU), Anand, Gujarat and
Dean, College of Veterinary Science andAnimal Hus-
bandry,AAU for providing the infrastructure facilities
aswellasfinancialhelptocarryouttheresearchwork.
Theauthorsdeclarethattheyhavenocompetinginterests.
etal
et al
et al
et al
etal
et al
et al
et al
et al
Conclusion
Authors' contributions
Acknowledgements
Competing interestsAvailable at www.veterinaryworld.org/Vol.7/July-2014/9.pdf
Veterinary World, EISSN: 2231-0916 495
References
1. Kremer, J. M. and Lee, J. K. (1988)Along term prospective
study of the use of methotrexate in rheumatoid arthritis.
,31:577-584.
2. Harris, E. D. (1990) Rheumatoid arthritis. Pathophysiology
andimplicationfortherapy.NEngl.J.Med.322:1277-1289.
3. Clavel, M., Vermorken, J. B. and Cognetti, F. (1994)
Randomized comparison of cisplatin, methotrexate,
bleomycin and vincristine versus cisplatin and 5 -
fluorouracil versus cisplatin in recurrent or metastatic
squamous cell carcinoma of the head and neck. A phase III
study of the EORTC head and neck cancer co-operative
group. 5:521-526.
4. Sterling, G. (1997) Methotrexate hepatotoxicity.
5. Hall, P. D., Jenner, M. A. and Ahern, M. J. (1991)
Hepatotoxicity in a rat model caused by orally administered
methotrexate. 14(5):906-10.
6. Cash, J. M. and Klippel, J. H. (1994) Second line drug
therapy for rheumatoid arthritis. 330: 1368-
1375.
7. Sorg, D. A. and Buckner, B. (1964) A simple method of
obtaining venous blood from small laboratory animals.
115:1131-2.
8. Ermens, A. A. M., Schoester, M., Spijkers, L. J. M.,
Lindemans, J. andAbels, J. (1989) Toxicity of methotrexate
in rat pre - exposed to nitrous oxide. 49: 6337-
6341.
9. Boukhettala, N., Leblond, J., Claeyssens, S., Faure, M.,
Pessot, F. L., Feysot, C. B., Hassan, A., Mettraux, C.,
Vuichoud, J., Lavoinne,A., Breuille, D., De'chelotte, P. and
Coeffier,M.(2009)Intestinalmucositisandaltersgutprotein
metabolism independently of reduced food intake.
296:182-190.
10. Perianayagasamy, A. M., Gomez, P. P. and Dhasarathan, P.
(2010) Therapeutical effect of melatonin and glutamine
against rats bone marrow toxicity induced by methotrexate.
11. Karri, S. and Vanithakumari, G. (2011) Effect of
methotrexate and leucovorin on female reproductive tract of
albinorats. .29:1–21.
12. Ohbayashi, M., Suzuki, M., Yashiro, Y., Fukuwaka, S.,
Yasuda, M., Kohyama, N., Kobayashi,Y. andYamamoto, T.
(2010) Induction of pulmonary fibrosis by methotrexate
treatment in mice lung in vivo and in vitro.
35(5):653-661.
13. Rofe,A. M., Bourgeois, C. S.,Washington, J. M., Philcox, J.
C. and Coyle, P. (1994) Metabolic consequences of
methotrexate therapy in tumour bearing rats.
72:43-48.
14. Bussanich,M.N.,Rootman,J.,Kumi,C.andGudauskas,G.
(1985) Ocular absorption and toxicity of methotrexate in the
dog. 26:263-266.
15. Robert,M.F.,Buckler,C.E.andBaron,S. (1961)Theeffect
ofaminomethylpteroylglutamicacidonthedevelopmentof
skin hypersensitivity and on antibody formation in guinea
pigs. United States Department of Health, Education and
Welfare, Public Health Service, National Institute of Health,
Division of Biologics Standards, laboratory of viral
immunology,Bethesda.
16. Vaghasiya, J., Bhalodia, Y. and Rathod, S. (2009) Drug
induced hepatotoxicity: effect of polyherbal formulation.
17. Uraz, S., Tahan, V., Aygun, C., Eren, F., Unluguzel, G.,
Yuksel, M., Senturk, O., Avsar, E., Haklar, G., Celikel, C.,
Hulagu, S. and Tozun, N. (2008) Role of ursodeoxycholic
acidinpreventionofmethotrexateinducedlivertoxicity.
53:1071-1077.
18. Coles, E. H. (1986) Veterinary clinical pathology. 4 edition
(ed. E. H. Coles) W. B. Saunders company, Philadelphia.
p10-42.
19. Al-motabagani, M. A. (2006) Histological and histo-
chemicalstudiesontheeffectsofmethotrexateontheliverof
adultmalealbinorat. 24(3):417-422.
20. Asci, H., Ozer, M. K., Calapoglu, M., Savran, M., Oncu,
M., Yesilot, S., Candan, I. A., Kulac, E. and Cicek, E.
(2011) Effects of misoprostol on methotrexate induced
hepaticandrenaldamages. 2(1):32-37.
21. Chelab, K. G. and Majeed, S. K. (2009) Methotrexate
induced histopathological changes in the kidneys of mice.
23:219-222.
22. Hanley M. J. (1980) Isolated nephron segments in a rabbit
model of ischemic acute renal failure. . 239:
17-13.
23. Arash,K.,Novin,M.G.,Khaki,A.A.,Nouri,M.andOzanci,
C. C. (2007) Effect of growth hormone on recovery from
testicular damage induced by methotrexate in rat.
.01/2008;26(1):65-65.
24. Khulood, W., Ismaeel A. H. and Abdulatif, A. W. (2010)
Effects of aqueous extract of on some parameters of
sperms and histopathological changes in testes of mice
treated with methotrexate. . 4(2):
3-10.
25. Safavi, S. E., Khayat, N. M. H., Khaki, A. and Serati N. H.
(2010) Effect of growth hormone on histomorphometerical
parameters of testis after methotrexate administration in rat.
6(1):23-29.
ArthritisRheum.
Ann.Oncol.
Hepatology.
N Engl J Med.
Exp
BiolMed.
Cancer Res.
Am J
Physiol-EndocM.
CellBiochemFunct
J Toxicol Sci.
Immunol Cell
Biol.
Can.VetJ.
Dig
DisSci.
Int.J.Morphol.
J.Biol.Life.Sci.
IraqiJ.Vet.Sci.
Am. J. Physiol
ReprodToxicol
salvia
J. Biotechnol. Res. Center
Vet.Res.
th
Rheum Dis
ClinNAm.
J.Biosci.Res
PhcogMag
23(4):883-915.
.1(3):202-207.
173-183.
5:232-237.
********